13D Filing: Kearny Venture Partners LP Files on Akebia Therapeutics, Inc. (AKBA)

Page 6 of 10

Page 6 of 10 SEC Filing

CUSIP NO. 00972D105 13D/A Page 6 of 10
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (Entities Only).

Caley Castelein (“Castelein”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)     ¨     (b)     x

3 SEC USE ONLY
4 SOURCE OF FUNDS WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S. citizen
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH
7

SOLE VOTING POWER

30,000 shares.

8

SHARED VOTING POWER

1,560,309 shares, of which 1,529,120 are owned directly by KVP and 31,189 are owned directly by KVPE.
Castelein is a managing member of KVA, which is the general
partner of both KVP and KVPE. Castelein may be deemed to have shared power to vote the shares held directly by KVP and KVPE.

9

SOLE DISPOSITIVE POWER

30,000 shares

10

SHARED DISPOSITIVE POWER

1,560,309 shares, of which 1,529,120 are owned directly by KVP and 31,189 are owned directly by KVPE.
Castelein is a managing member of KVA, which is the general
partner of both KVP and KVPE. Castelein may be deemed to have shared power to dispose of the shares held directly by KVP and KVPE.

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,590,309
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.2%
14 TYPE OF REPORTING PERSON (See Instructions) IN

Follow Akebia Therapeutics Inc. (NASDAQ:AKBA)

Page 6 of 10